Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2006 1
2007 1
2008 6
2009 5
2010 14
2011 17
2012 33
2013 67
2014 101
2015 143
2016 192
2017 276
2018 267
2019 331
2020 456
2021 562
2022 290
Text availability
Article attribute
Article type
Publication date

Search Results

2,461 results
Results by year
Filters applied: . Clear all
Page 1
Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma S, Tripathi P. Sharma S, et al. J Nutr Biochem. 2019 Jan;63:101-108. doi: 10.1016/j.jnutbio.2018.10.003. Epub 2018 Oct 11. J Nutr Biochem. 2019. PMID: 30366260 Review.
Type 2 diabetes mellitus (T2D) is a highly prevalent metabolic disorder characterized by an imbalance in blood glucose level, altered lipid profile and high blood pressure. ...We reviewed the published literature for better understanding of the dynamic
Type 2 diabetes mellitus (T2D) is a highly prevalent metabolic disorder characterized by an imbalance in blood g
Role of gut microbiota in type 2 diabetes pathophysiology.
Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, Shulzhenko N. Gurung M, et al. EBioMedicine. 2020 Jan;51:102590. doi: 10.1016/j.ebiom.2019.11.051. Epub 2020 Jan 3. EBioMedicine. 2020. PMID: 31901868 Free PMC article. Review.
A substantial body of literature has provided evidence for the role of gut microbiota in metabolic diseases including type 2 diabetes. However, reports vary regarding the association of particular taxonomic groups with disease. In this systematic revie …
A substantial body of literature has provided evidence for the role of gut microbiota in metabolic diseases including type
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
Foretz M, Guigas B, Viollet B. Foretz M, et al. Nat Rev Endocrinol. 2019 Oct;15(10):569-589. doi: 10.1038/s41574-019-0242-2. Epub 2019 Aug 22. Nat Rev Endocrinol. 2019. PMID: 31439934 Free article. Review.
Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the mechanisms underlying the plasma glucose level-lowering effects of metformin (1,1-dimethylbiguanide) still remain incompletely understood. ...Furthermore, the ga …
Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the mechanisms underlying …
Research progress in the relationship between type 2 diabetes mellitus and intestinal flora.
Ma Q, Li Y, Li P, Wang M, Wang J, Tang Z, Wang T, Luo L, Wang C, Wang T, Zhao B. Ma Q, et al. Biomed Pharmacother. 2019 Sep;117:109138. doi: 10.1016/j.biopha.2019.109138. Epub 2019 Jun 24. Biomed Pharmacother. 2019. PMID: 31247468 Free article. Review.
Type 2 diabetes mellitus (T2DM) is a common clinical chronic disease, while its pathogenesis is still inconclusive. Intestinal flora, the largest micro-ecological system in the human body, is involved in, meanwhile has a major impact on the body's
Type 2 diabetes mellitus (T2DM) is a common clinical chronic disease, while its pathogenesis is still inconclusi
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
Brunkwall L, Orho-Melander M. Brunkwall L, et al. Diabetologia. 2017 Jun;60(6):943-951. doi: 10.1007/s00125-017-4278-3. Epub 2017 Apr 22. Diabetologia. 2017. PMID: 28434033 Free PMC article. Review.
During the last decade, evidence has accumulated to support a role for gut microbiota (analysed from faecal samples) in glycaemic control and type 2 diabetes. ...We discuss what is known about the composition and functionality of human gut microbiot
During the last decade, evidence has accumulated to support a role for gut microbiota (analysed from faecal samples) in glycaemic con …
Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A, Diaz-Perdigones C, Tinahones FJ. Muñoz-Garach A, et al. Endocrinol Nutr. 2016 Dec;63(10):560-568. doi: 10.1016/j.endonu.2016.07.008. Epub 2016 Sep 12. Endocrinol Nutr. 2016. PMID: 27633134 Review. English, Spanish.
In recent years, many studies have related gut microbiome to development of highly prevalent diseases such as type 2 diabetes and obesity. ...There are several mechanisms that relate microbiota to the onset of insulin resistance and diabetes
In recent years, many studies have related gut microbiome to development of highly prevalent diseases such as type 2
Precision nutrition for prevention and management of type 2 diabetes.
Wang DD, Hu FB. Wang DD, et al. Lancet Diabetes Endocrinol. 2018 May;6(5):416-426. doi: 10.1016/S2213-8587(18)30037-8. Epub 2018 Feb 9. Lancet Diabetes Endocrinol. 2018. PMID: 29433995 Review.
Recent advances in genomics, metabolomics, and gut microbiome technologies have offered opportunities as well as challenges in the use of precision nutrition to prevent and manage type 2 diabetes. ...Therefore, we should manage unrealistically high exp …
Recent advances in genomics, metabolomics, and gut microbiome technologies have offered opportunities as well as challenges in the us …
Arrhythmic Gut Microbiome Signatures Predict Risk of Type 2 Diabetes.
Reitmeier S, Kiessling S, Clavel T, List M, Almeida EL, Ghosh TS, Neuhaus K, Grallert H, Linseisen J, Skurk T, Brandl B, Breuninger TA, Troll M, Rathmann W, Linkohr B, Hauner H, Laudes M, Franke A, Le Roy CI, Bell JT, Spector T, Baumbach J, O'Toole PW, Peters A, Haller D. Reitmeier S, et al. Cell Host Microbe. 2020 Aug 12;28(2):258-272.e6. doi: 10.1016/j.chom.2020.06.004. Epub 2020 Jul 2. Cell Host Microbe. 2020. PMID: 32619440 Free article.
Lifestyle, obesity, and the gut microbiome are important risk factors for metabolic disorders. We demonstrate in 1,976 subjects of a German population cohort (KORA) that specific microbiota members show 24-h oscillations in their relative abundance and identified 13 …
Lifestyle, obesity, and the gut microbiome are important risk factors for metabolic disorders. We demonstrate in 1,976 subjects of a …
Interpretable Machine Learning Framework Reveals Robust Gut Microbiome Features Associated With Type 2 Diabetes.
Gou W, Ling CW, He Y, Jiang Z, Fu Y, Xu F, Miao Z, Sun TY, Lin JS, Zhu HL, Zhou H, Chen YM, Zheng JS. Gou W, et al. Diabetes Care. 2021 Feb;44(2):358-366. doi: 10.2337/dc20-1536. Epub 2020 Dec 7. Diabetes Care. 2021. PMID: 33288652 Free PMC article.
RESEARCH DESIGN AND METHODS: We used an interpretable machine learning framework to identify the type 2 diabetes-related gut microbiome features in the cross-sectional analyses of three Chinese cohorts: one discovery cohort (n = 1,832, 270 cases of …
RESEARCH DESIGN AND METHODS: We used an interpretable machine learning framework to identify the type 2 diabetes-relate …
The subgingival microbiome associated with periodontitis in type 2 diabetes mellitus.
Shi B, Lux R, Klokkevold P, Chang M, Barnard E, Haake S, Li H. Shi B, et al. ISME J. 2020 Feb;14(2):519-530. doi: 10.1038/s41396-019-0544-3. Epub 2019 Oct 31. ISME J. 2020. PMID: 31673077 Free PMC article.
Type 2 diabetes mellitus (T2DM) is a systemic disease, predisposing patients to other inflammatory conditions including periodontitis. The subgingival microbiome, a key player in periodontitis pathogenesis, is not well characterized in T2DM popu
Type 2 diabetes mellitus (T2DM) is a systemic disease, predisposing patients to other inflammatory conditions in
2,461 results